N-乙醯半胱胺酸市場規模、佔有率和成長分析（按類型、應用和地區）- 產業預測，2025-2032 年

2023 年全球 N-乙醯半胱胺酸市場規模價值 15 億美元，預計將從 2024 年的 18.4 億美元成長到 2032 年的 92.5 億美元，預測期內（2025-2032 年）的複合年成長率為 22.4%。

乙醯半胱胺酸（NAT）是治療對乙醯胺酚過量攝取和緩解肺炎、支氣管炎等慢性呼吸道疾病中的濃稠黏液的重要治療劑。它也用於治療新生兒乳酸桿菌病，可以透過注射、口服或吸入給藥。它作為膳食補充劑越來越受歡迎，但您應該注意潛在的副作用，包括噁心、嘔吐和皮膚刺激。乙醯半胱胺酸通常被認為在懷孕期間是安全的，它透過增加麩胺基硫水平來對抗對乙醯胺酚的毒性，從而中和其有害的分解產物。此外，當吸入時，它可以作為粘液溶解劑，有效降低粘液的粘度。這種多方面的功能使乙醯半胱胺酸成為各種臨床和補充應用的寶貴選擇。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析

N-乙醯半胱胺酸市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• 錠劑
• 噴
• 氣管灌注
• 其他

N-乙醯半胱胺酸市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 藥品
• 營養補充品
• 其他

N-乙醯半胱胺酸市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Taizhou Tianhong Biochemistry Technology Co., Ltd.（China）
• Zhejiang Kangle Pharmaceutical Co., Ltd.（China）
• Wuhan Wuyao Pharmaceutical Co., Ltd.（China）
• Shijiazhuang Haitian Amino Acid Co., Ltd.（China）
• Jiangsu Gedi Biological Engineering Co., Ltd.（China）
• Nantong Baihua Bio-pharmaceutical Co., Ltd.（China）
• Changzhou Yabang-QH Pharmachem Co., Ltd.（China）
• Anhui Leafchem Co., Ltd.（China）
• Huahai Pharmaceutical Co., Ltd.（China）
• Hebei Guangren Pharmaceutical Technology Co., Ltd.（China）
• Sichuan Mingxin Pharmaceutical Co., Ltd.（China）
• Hangzhou Hyper Chemicals Limited（China）
• Sigma-Aldrich Corporation（USA）
• Alfa Aesar（USA）（now part of Thermo Fisher Scientific, USA）
• Mylan NV（USA）（now Viatris Inc., USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Hikma Pharmaceuticals PLC（UK）
• NOW Foods（USA）
• Life Extension（USA）

結論和建議

Global N-Acetylcysteine Market size was valued at USD 1.5 billion in 2023 and is poised to grow from USD 1.84 billion in 2024 to USD 9.25 billion by 2032, growing at a CAGR of 22.4% during the forecast period (2025-2032).

Acetylcysteine (NAT) serves as a vital therapeutic agent for addressing paracetamol overdoses and alleviating thick mucus in chronic respiratory conditions like pneumonia and bronchitis. Additionally, it provides treatment for lactobezoar in newborns and can be administered through injection, oral ingestion, or inhalation. While it is increasingly popular as a dietary supplement, users should be aware of potential side effects such as nausea, vomiting, and skin irritation. Acetylcysteine is generally considered safe during pregnancy and combats paracetamol toxicity by elevating glutathione levels, which neutralize harmful breakdown products. Furthermore, when inhaled, it acts as a mucolytic agent, effectively reducing mucus viscosity. This multi-faceted functionality positions acetylcysteine as a valuable option in various clinical and supplemental applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global N-Acetylcysteine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global N-Acetylcysteine Market Segmental Analysis

Global N-Acetylcysteine Market is segmented by Type, Application and region. Based on Type, the market is segmented into Tablet, Spray, Tracheal drip and Other. Based on Application, the market is segmented into Medicines, Nutritional Supplements and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global N-Acetylcysteine Market

The global N-Acetylcysteine market is primarily driven by the increasing demand from the healthcare sector. This antioxidant is recognized for its potential to help prevent cancer and is commonly used in medical settings to treat acetaminophen toxicity by effectively binding to the harmful metabolites produced in the liver. Moreover, N-acetyl cysteine is frequently employed for addressing respiratory conditions, including coughs. While it is also suggested for various other health issues such as the flu and dry eyes, it's important to note that many of these claims lack robust scientific backing. Additionally, its effectiveness in treating COVID-19 remains unproven.

Restraints in the Global N-Acetylcysteine Market

The global N-Acetylcysteine market faces certain restraints primarily due to the potential side effects associated with its use. While N-acetylcysteine is generally well tolerated at lower doses, such as 1,200 mg taken twice daily, some patients may experience uncommon side effects including nausea, vomiting, diarrhea, rashes, flushing, stomach discomfort, and constipation. At significantly higher doses, often utilized for acetaminophen overdose, adverse reactions may occur, such as headaches, tinnitus, hives, chills, fever, and even anaphylactoid responses. Furthermore, N-acetylcysteine can enhance the effects of nitroglycerin and similar medications, necessitating caution in patients at risk of hypotension.

Market Trends of the Global N-Acetylcysteine Market

The Global N-Acetylcysteine (NAC) market is witnessing a notable trend driven by expanding research and clinical applications. Originally recognized for its role as a mucolytic agent and an antidote to acetaminophen overdose, recent studies indicate NAC's potential effectiveness in addressing various health conditions, including mental health disorders and neurological diseases. The ongoing exploration of its benefits in relation to COVID-19 further complements its growing therapeutic portfolio. This broadened scientific inquiry is expected to fuel demand in the pharmaceutical and nutraceutical sectors, positioning NAC as a vital component in modern healthcare and contributing to market growth through 2024 and beyond.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global N-Acetylcysteine Market Size by Type & CAGR (2025-2032)

• Market Overview
• Tablet
• Spray
• Tracheal drip
• Other

Global N-Acetylcysteine Market Size by Application & CAGR (2025-2032)

• Market Overview
• Medicines
• Nutritional Supplements
• Others

Global N-Acetylcysteine Market Size & CAGR (2025-2032)

• North America (Type, Application)
  • US
  • Canada
• Europe (Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Taizhou Tianhong Biochemistry Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang Kangle Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuhan Wuyao Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shijiazhuang Haitian Amino Acid Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Gedi Biological Engineering Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nantong Baihua Bio-pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Changzhou Yabang-QH Pharmachem Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anhui Leafchem Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huahai Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hebei Guangren Pharmaceutical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sichuan Mingxin Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hangzhou Hyper Chemicals Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alfa Aesar (USA) (now part of Thermo Fisher Scientific, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA) (now Viatris Inc., USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NOW Foods (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Life Extension (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations